Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

BACKGROUND: The use of Direct Oral Anticoagulants (DOACs) in patients who have both atrial fibrillation (AF) and end-stage renal disease (ESRD) requiring hemodialysis remains controversial, with warfarin remaining the mainstay of the treatment. As hemodialysis patients were excluded from most clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfar, Sohil, Elzeiny, Sara Mohamed, Ismail, Hesham, Makkeyah, Yahya, Ibrahim, Mokhtar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218480/
https://www.ncbi.nlm.nih.gov/pubmed/35757350
http://dx.doi.org/10.3389/fcvm.2022.847286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218480/
https://www.ncbi.nlm.nih.gov/pubmed/35757350
http://dx.doi.org/10.3389/fcvm.2022.847286

Ejemplares similares